MannKind Corporation (MNKD) – Financial and Strategic SWOT Analysis Review

MannKind Corporation (MNKD) – Financial and Strategic SWOT Analysis Review Cover

Single Licence: $125

Buy Now
customer(s) bought this report
BUY WITH CONFIDENCE

Shopping on CFDMaster.com is Safe and Secure. GUARANTEED!
All information is encrypted and handled by PayPal.com

Need Assistance?
Have you got questions about this report? Why not speak to one of our advisors. Email us at business@cfdmaster.com or call us at +61 (02) 8011 3208
# Pages
Market
Country
Single User
Site License
Enterprisewide
44
Pharmaceuticals and Healthcare
United States

MannKind Corporation (MNKD) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MannKind Corporation (MannKind) is a bio-pharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products to treat diseases such as diabetes and cancer. The company’s product pipeline include its lead product, MannKind Corporation (MannKind) is a bio-pharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products to treat diseases such as diabetes and cancer. The company’s product portfolio comprises one marketed product Afrezza, a rapid-acting inhaled insulin aimed to enhance glycemic control and is indicated for the treatment of diabetes.

MannKind Corporation Key Recent Developments

Feb 24, 2015 MannKind Reports 2014 Fourth Quarter and Full Year Financial Results
Jan 12, 2015 MannKind CEO Alfred Mann to Transition to Executive Chairman; COO and President Hakan Edstrom Appointed to CEO
Nov 03, 2014 MannKind Reports 2014 Third Quarter Financial Results
Aug 11, 2014 MannKind Reports 2014 Second Quarter Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Table of Contents

Section 1 – About the Company 6
MannKind Corporation – Key Facts 6
MannKind Corporation – Key Employees 7
MannKind Corporation – Key Employee Biographies 8
MannKind Corporation – Major Products and Services 9
MannKind Corporation – Medical Equipment Pipeline Products Data 10
MannKind Corporation Pipeline Products by Equipment Type 10
MannKind Corporation Pipeline Products by Development Stage 12
MannKind Corporation – History 14
MannKind Corporation – Company Statement 16
MannKind Corporation – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Section 2 – Company Analysis 18
MannKind Corporation – Business Description 18
MannKind Corporation – Corporate Strategy 19
MannKind Corporation – SWOT Analysis 20
SWOT Analysis – Overview 20
MannKind Corporation – Strengths 20
Strength – First-in-Class Product – Afrezza 20
Strength – Focused Research and Development 20
Strength – Technosphere Technology Platform 20
MannKind Corporation – Weaknesses 21
Weakness – History of Operating Losses 21
Weakness – Delay in Launch of Afreezza 21
Weakness – Dependence on Sanofi for Commercialization 21
MannKind Corporation – Opportunities 22
Opportunity – Increased Aged Population 22
Opportunity – Diabetes Market Potential 22
MannKind Corporation – Threats 23
Threat – Competitive Pressures 23
Threat – Government Regulations 23
Threat – Rapid Changes in Technology 23
MannKind Corporation – Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios – Capital Market Ratios 25
Financial Ratios – Annual Ratios 26
Financial Performance 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
MannKind Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 28
MannKind Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 29
MannKind Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015 30
MannKind Corporation, Medical Equipment, Deals By Type, 2009 to YTD 2015 31
MannKind Corporation, Recent Deals Summary 32
Section 5 – Company’s Recent Developments 33
Feb 24, 2015: MannKind Reports 2014 Fourth Quarter and Full Year Financial Results 33
Jan 12, 2015: MannKind CEO Alfred Mann to Transition to Executive Chairman; COO and President Hakan Edstrom Appointed to CEO 34
Nov 03, 2014: MannKind Reports 2014 Third Quarter Financial Results 35
Aug 11, 2014: MannKind Reports 2014 Second Quarter Financial Results 36
May 12, 2014: MannKind Reports 2014 First Quarter Financial Results 37
Feb 18, 2014: MannKind Reports 2013 Fourth Quarter and Full Year Financial Results 38
Jan 08, 2014: MannKind to Present at the J.P. Morgan 2014 Healthcare Conference 39
Section 6 – Appendix 40
Methodology 40
Ratio Definitions 40
About GlobalData 44
Contact Us 44
Disclaimer 44



List of Tables
MannKind Corporation, Key Facts 6
MannKind Corporation, Key Employees 7
MannKind Corporation, Key Employee Biographies 8
MannKind Corporation, Major Products and Services 9
MannKind Corporation Number of Pipeline Products by Equipment Type 10
MannKind Corporation Pipeline Products by Equipment Type 11
MannKind Corporation Number of Pipeline Products by Development Stage 12
MannKind Corporation Pipeline Products by Development Stage 13
MannKind Corporation, History 14
MannKind Corporation, Other Locations 17
MannKind Corporation, Key Competitors 24
MannKind Corporation, Ratios based on current share price 25
MannKind Corporation, Annual Ratios 26
MannKind Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 28
MannKind Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 29
MannKind Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015 30
MannKind Corporation, Medical Equipment, Deals By Type, 2009 to YTD 2015 31
MannKind Corporation, Recent Deals Summary 32
Capital Market Ratios 40
Equity Ratios 41
Profitability Ratios 41
Cost Ratios 42
Liquidity Ratios 42
Leverage Ratios 43
Efficiency Ratios 43



List of Figures
MannKind Corporation Pipeline Products by Equipment Type 10
MannKind Corporation Pipeline Products by Development Stage 12
MannKind Corporation, Ratio Charts 27
MannKind Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 28
MannKind Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 29
MannKind Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015 30
MannKind Corporation, Medical Equipment, Deals by Type, 2009 to YTD 2015 31

Report Delivery

PDF SWOT Analysis Report An Electronic PDF copy of this Report will be sent to you via email.

Please allow up to 2 business days for the reports to arrive to your mailbox as some of our publishers prefer to send you the reports directly.

Purchase this Report today

Price: $125

Report Licences Explanation

* Single User: Electronic PDF copy delivered via email. Report can be used by individual purchaser only.

* Site License: Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.

* Enterprise Wide License: Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.

If you require a Site License or Enterprise Wide License please contact us to issue you an invoice.

Customers who Viewed this Report also Viewed

Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.